Associated Papers
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.
Lévy R et al.
The Journal of Experimental Medicine, 2023
Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency.
Kolukisa B et al.
Allergy, 2022
Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy.
Zhu Y et al.
Frontiers in Pediatrics, 2022
Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.
Bosa L et al.
Scientific Reports, 2021
Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency.
Alazami AM et al.
Frontiers in Immunology, 2018
A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction.
Sorte HS et al.
Molecular Genetics & Genomic Medicine, 2016
Select a paper to view details